precision medicine projects

Results for: Clinical and economic impact assessment

UMBRELLA-SUMMA LEGACY
Integration of polygenic risk scores with multiparametric information in patient-specific prediction of the onset, progression, and therapeutic response to atrial fibrillation
PMP22/00030
2025
ANDALUSIA, CANTABRIA, CASTILLA LA MANCHA, CATALONIA, COMMUNITY OF VALENCIA, EXTREMADURA, BALEARIC ISLANDS, LA RIOJA, MADRID, BASQUE COUNTRY
Dr. Ferran Barbé Illa
Impact of Sleep Respiratory Disorder Management on the Control of Systemic Hypertension: METASLEEP Project
Therapeutic Targets and Biomarkers for Precision Medicine in MAFLD (PreMed-MAFLD)
PMP-DEGESCO: Validation of a precision medicine tool based on online cognitive evaluation, genetic risk stratification and bloodbased biomarkers for identification of preclinical Alzheimer’s Disease.
Clinical validation of OPTIBIO algorithm to predict persistent remission in rheumatoid arthritis patients treated with biological therapy. (REMRABIT- plus).
Prediction of cardiotoxicity risk in cardio-oncology units. Value of genetics and different biomarkers. The CARDIOTOX Registry
PMP22/00101
2022
GALICIA
Francisco Javier Blanco García
Clinical validation of the OPTIBIO algorithm to predict persistent remission in patients with rheumatoid arthritis treated with biologic therapy. (REMRABIT-plus)
Precision biomarkers for improving the diagnosis and treatment of inflammatory myocardial disease (PreMYO)
PMP22/00004
2022
CATALONIA
AVILÉS JURADO, FRANCISCO JAVIER
Multi-omics characterization of squamous cell carcinoma of the head and neck by gaseous and liquid biopsy: diagnostic, prognostic and follow-up application. HN-OMICS
1 / 21
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.